These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10550827)

  • 1. Radiosensitization by gemcitabine.
    Lawrence TS; Eisbruch A; McGinn CJ; Fields MT; Shewach DS
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):55-60. PubMed ID: 10550827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-mediated radiosensitization.
    Lawrence TS; Eisbruch A; Shewach DS
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-24-S7-28. PubMed ID: 9194476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
    Azria D; Coelho M; Larbouret C; Lemanski C; Serre A; Ychou M; Pèlegrin A; Dubois JB; Culine S
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S106-13. PubMed ID: 15679255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gemcitabine and ionizing radiations: radiosensitization or radio-chemotherapy combination].
    Azria D; Jacot W; Prost P; Culine S; Ychou M; Lemanski C; Dubois JB
    Bull Cancer; 2002 Apr; 89(4):369-79. PubMed ID: 12016038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality therapy of gemcitabine and radiation.
    Pauwels B; Korst AE; Lardon F; Vermorken JB
    Oncologist; 2005 Jan; 10(1):34-51. PubMed ID: 15632251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined gemcitabine and radiotherapy].
    Mornex F
    Bull Cancer; 2002 Aug; 89 Spec No():S127-33. PubMed ID: 12449044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
    Eisbruch A; Shewach DS; Bradford CR; Littles JF; Teknos TN; Chepeha DB; Marentette LJ; Terrell JE; Hogikyan ND; Dawson LA; Urba S; Wolf GT; Lawrence TS
    J Clin Oncol; 2001 Feb; 19(3):792-9. PubMed ID: 11157033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
    Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemoradiotherapy with gemcitabine: potential applications.
    Choy H
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):20-5. PubMed ID: 10960941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.
    Crane CH; Wolff RA; Abbruzzese JL; Evans DB; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Lahoti S; Vauthey JN; Janjan NA
    Semin Oncol; 2001 Jun; 28(3 Suppl 10):25-33. PubMed ID: 11510031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
    McGinn CJ; Lawrence TS; Zalupski MM
    Cancer; 2002 Aug; 95(4 Suppl):933-40. PubMed ID: 12209674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine and radiosensitization in human tumor cells.
    Shewach DS; Lawrence TS
    Invest New Drugs; 1996; 14(3):257-63. PubMed ID: 8958180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization.
    Lawrence TS; Davis MA; Hough A; Rehemtulla A
    Clin Cancer Res; 2001 Feb; 7(2):314-9. PubMed ID: 11234886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of human solid tumor cell lines with gemcitabine.
    Shewach DS; Lawrence TS
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):65-71. PubMed ID: 8893885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New applications of gemcitabine and future directions in the management of pancreatic cancer.
    Abbruzzese JL
    Cancer; 2002 Aug; 95(4 Suppl):941-5. PubMed ID: 12209675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine plus radiotherapy for non-small cell lung cancer.
    Gregor A
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-39-S8-41. PubMed ID: 9207316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concurrent chemoradiation therapy with gemcitabine for advanced or relapsed pancreatic tumors].
    Ioka T; Nakaizumi A; Tanaka S; Yamazaki H; Nishiyama K
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():248-53. PubMed ID: 16457260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gemcitabine: a new chemotherapy agent for solid cancers].
    Klastersky J; Awada A
    Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
    Allen AM; Zalupski MM; Robertson JM; Eckhauser FE; Simone D; Brown D; Hejna G; Normolle D; Lawrence TS; McGinn CJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1461-7. PubMed ID: 15275733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.
    Aguilar-Ponce J; Granados-García M; Villavicencio V; Poitevin-Chacón A; Green D; Dueñas-González A; Herrera-Gómez A; Luna-Ortiz K; Alvarado A; Martínez-Said H; Castillo-Henkel C; Segura-Pacheco B; De la Garza J
    Ann Oncol; 2004 Feb; 15(2):301-6. PubMed ID: 14760126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.